There have been no genomic studies showing PSD4/EFA6B to be a tumor suppressor gene, and our orthotopic xenograft experiments with MCF10A WT or EFA6BKO cells injected into immunosuppressed mice did not produce any tumor arguing that the loss of EFA6B alone is not a driver mutation. The gene discussed is PSD4; the disease is neoplasm.